Results - Announcements
Solara Active Pharma Sciences Ltd share price headed higher 6.66% to Rs 696.3 after the company's net profit saw a strong growth of 74.49% to Rs 28.46 crore, while revenue from operations slightly gained 9.37% to Rs 417.34 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 26.82 lakh crore, rising 4.13%. It has slipped by 0.73% over last one week and gained upto 0.56% in last one month while the market capitalization of Solara Active Pharma Sciences Ltd has improved by 7.90% and 23.88% in the same period respectively.
Profit before tax (PBT) of Solara Active Pharma Sciences Ltd stood at Rs 28.46 crore in Q3 FY26, tumbling by 381.78% year-on-year, and expanding by 74.49% quarter-on-quarter. EBITDA came in at Rs 76 crore, rallying 122.84% YoY and surging by 28.71% sequentially.
Total expenses saw a slight increase of 6.01% to Rs 367.14 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 217.8 crore, witnessing a sharp rise of 20.46% YoY, while employee benefits expense was at Rs 57.62 crore, easing 2.80% YoY.
For the TTM ended FY26, revenue from operations tick up 6.64% to Rs 1368.98 crore, while net profit witnessed a sharp fall of 1472.22% to Rs 7.41 crore, compared to previous TTM. EBITDA surged by 19739% to Rs 180.59 crore, and PBT tanked by 1472.22% to Rs 7.41 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 152.91 crore in FY26, as against Rs 212.82 crore in FY25.
Solara Active Pharma Sciences Ltd jumped 17.68% in last one year, significantly outperforming the benchmark BSE Sensex which has declined by 10.47% during the same period.